Editorial

View All
Your Trusted Source for Biopharma News
Editorial Resilience Is the New Biopharma Blockbuster

The biopharmaceutical sector is entering a new era. After last year's market disruptions, the industry faces a harsh truth: scientific breakthroughs alone are no longer enough to keep ahead of the…

How Tissue Engineering Is Redefining R&D and Regenerative Care
EditorialHow Tissue Engineering Is Redefining R&D and Regenerative Care

By 2030, the tissue-engineering market is projected to exceed $32.45 billion , reflecting a

BridgeBio's Breakthrough in Limb-Girdle Muscular Dystrophy Trials
EditorialBridgeBio's Breakthrough in Limb-Girdle Muscular Dystrophy Trials

The landscape of rare disease drug development is littered with clinical failures. For every

Price Pressures Are Here: How to Plan, Launch & LCM in the IRA Era
EditorialPrice Pressures Are Here: How to Plan, Launch & LCM in the IRA Era

Major policy changes are colliding with the complex economics of drug development. For B2B

Building Resilience in Biopharma Amid Global Disruptions
EditorialBuilding Resilience in Biopharma Amid Global Disruptions

Biopharma companies have always operated at the edge of uncertainty. Scientific discovery is

View All

Research & Development

View All
View All

Tech & Innovation

View All
View All
Shutdown Disrupts Medicare Telehealth and At-Home Care
Tech & Innovation Shutdown Disrupts Medicare Telehealth and At-Home Care

A brief but deeply impactful federal government shutdown has thrown crucial healthcare services into disarray, abruptly halting the pandemic-era Medicare telehealth and Hospital-at-Home flexibilities that have become a lifeline for millions of Americans. This funding lapse, triggered by a

Digital Labs Are Accelerating Scientific Discovery
Tech & InnovationDigital Labs Are Accelerating Scientific Discovery

The rapid evolution of technology is fundamentally reshaping the landscape of scientific research

AI Improves Breast Cancer Detection in Landmark Study
Tech & InnovationAI Improves Breast Cancer Detection in Landmark Study

With us today is Ivan Kairatov, a biopharma expert with deep knowledge of technological innovation

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later